Xencor Inc (XNCR.OQ)
24 Apr 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|46||2015||President, Chief Executive Officer, Founder, Director|
|52||2016||Senior Vice President, Research and Chief Scientific Officer|
|63||2015||Senior Vice President, Chief Medical Officer|
|57||2010||Vice President - Finance|
|57||2010||Chief Business Officer|
- BRIEF-Xencor Says Public Offering Of 7.30 Mln Common Shares Priced At $31 Per Share
- BRIEF-Xencor Files For Potential Mixed Shelf Offering
- BRIEF-Xencor Announces Proposed Public Offering Of Common Stock
- BRIEF-Xencor Reports Q4 Loss Per Share $0.25
- BRIEF-Xencor Doses First Patient In Phase 1 Study Of Xmab®18087,An Antibody For Treatment Of Neuroendocrine Tumors And Gastrointestinal Stromal Tumors